Zentek (CVE:ZEN) Stock Price Up 16.9% – Time to Buy?

Zentek Ltd. (CVE:ZEN) shares rose 16.9% on Friday . The company traded as high as C$0.70 and last traded at C$0.69. Approximately 103,172 shares changed hands during trading, an increase of 62% from the average daily volume of 63,595 shares. The stock had previously closed at C$0.59.

Zentek Trading Up 16.9%

The firm has a market capitalization of C$74.21 million, a price-to-earnings ratio of -8.63 and a beta of 0.36. The business’s 50-day simple moving average is C$0.76 and its two-hundred day simple moving average is C$0.95. The company has a quick ratio of 7.59, a current ratio of 1.00 and a debt-to-equity ratio of 15.41.

Zentek Company Profile

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada.